Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline and Progress toward Launch Readiness

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline and Progress toward Launch Readiness

Sage Therapeutics (SAGE) PT Lowered to $261 at RBC Capital

May 4, 2018 8:47 AM EDT

RBC Capital lowered its price target on Sage Therapeutics (NASDAQ: SAGE) to $261.00 (from $277.00) while maintaining a Outperform rating.

... More